Your browser doesn't support javascript.
loading
Immunogenicity and safety of concomitant and sequential administration of yellow fever YF-17D vaccine and tetravalent dengue vaccine candidate TAK-003: A phase 3 randomized, controlled study.
Tricou, Vianney; Essink, Brandon; Ervin, John E; Turner, Mark; Escudero, Ian; Rauscher, Martina; Brose, Manja; Lefevre, Inge; Borkowski, Astrid; Wallace, Derek.
Afiliação
  • Tricou V; Takeda Pharmaceuticals International AG, Zurich, Switzerland.
  • Essink B; Meridian Clinical Research, Omaha, Nebraska, United States of America.
  • Ervin JE; Center for Pharmaceutical Research Inc, Kansas City, Missouri, United States of America.
  • Turner M; Advanced Clinical Research, Boise, Idaho, United States of America.
  • Escudero I; Takeda Vaccines Pte. Ltd., Singapore.
  • Rauscher M; Takeda Pharmaceuticals International AG, Zurich, Switzerland.
  • Brose M; Takeda Pharmaceuticals International AG, Zurich, Switzerland.
  • Lefevre I; Takeda Pharmaceuticals International AG, Zurich, Switzerland.
  • Borkowski A; Takeda Pharmaceuticals International AG, Zurich, Switzerland.
  • Wallace D; Takeda Vaccines Inc., Boston, Massachusetts, United States of America.
PLoS Negl Trop Dis ; 17(3): e0011124, 2023 03.
Article em En | MEDLINE | ID: mdl-36888687
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Febre Amarela / Vacina contra Febre Amarela / Dengue / Vacinas contra Dengue Tipo de estudo: Clinical_trials Limite: Adult / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Febre Amarela / Vacina contra Febre Amarela / Dengue / Vacinas contra Dengue Tipo de estudo: Clinical_trials Limite: Adult / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article